Validation of Osmolarity System: Clinical Usability Study
- Conditions
- Dry Eye
- Registration Number
- NCT03769324
- Lead Sponsor
- I-MED Pharma
- Brief Summary
Confirmatory trial to validate usability of a new portable osmolarity testing device.
- Detailed Description
Confirmatory trial at 3 sites in Canada to validate usability of an ocular osmolarity testing device.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Able to provide consent
Exclusion Criteria
- Ocular pathology (other than Dry Eye)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Osmolarity Level Baseline Osmolarity Level
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link tear osmolarity to dry eye disease progression in clinical usability studies?
How does the I-MED Pharma portable osmolarity device compare to standard-of-care diagnostics for dry eye in terms of accuracy and patient compliance?
Which biomarkers correlate with tear osmolarity measurements to predict response to dry eye therapies like cyclosporine or lifitegrast?
What adverse events are associated with ocular osmolarity testing using the I-MED Pharma device in observational trials?
How might osmolarity data from NCT03769324 influence combination therapies for dry eye subtypes (aqueous-deficient vs. evaporative)?